Marco Solmi, MD, PhD

Department of Psychiatry, University of Ottawa, Ontario, Canada; Regional Centre for the Treatment of Eating Disorders and On Track: The Champlain First Episode Psychosis Program, Department of Mental Health, The Ottawa Hospital, Ontario, Canada; Ottawa Hospital Research Institute (OHRI), Clinical Epidemiology Program University of Ottawa, Ontario, Canada; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany

Relative Risk of Breast Cancer Associated With Prolactin-Increasing Antipsychotic Use

Letter to the Editor

Relative Risk of Breast Cancer Associated With Prolactin-Increasing Antipsychotic Use

January 22, 2024

The authors provide additional relative risk data in response to Dr Andrade’s comments on their study.

Heidi Taipale, Marco Solmi, Christoph U. Correll, et al

Antipsychotic Dose and Weight Gain

Meta-Analysis

Antipsychotic Dose and Weight Gain

February 8, 2023

Although effects on weight gain have been explored for several antipsychotics, the role of dose in producing these effects has not been widely studied. This meta-analysis examined the association...

Michel Sabé, Konstantinos Pallis, Marco Solmi, et al

QTc Prolongation in Psychiatric Hospitalization

Original Research

QTc Prolongation in Psychiatric Hospitalization

February 17, 2022

QTc prolongation increases the risk of severe ventricular arrhythmias, in particular torsades de pointes. This study measured the prevalence of QTc prolongation in inpatients with severe mental illness to...

Benedetta Salvati, Alessandro Miola, Tommaso Toffanin, et al

Article

Low Hemoglobin and Depression

December 28, 2016

Although studies have suggested an association between anemia and depression in the elderly, prospective research has yet to clarify of the directionality of that association. Read this article to...

Caterina Trevisan, Nicola Veronese, Francesco Bolzetta, et al